Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
19 participants
OBSERVATIONAL
2014-04-14
2019-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main objective of this project is to describe the metabolic changes that occur during a typical surgical procedure in detail. In order to measure the alterations in the balanced use of sugar, fat, and protein during surgery we will collect blood samples from patients before, during, and after spinal surgical procedures. Subjects will be enrolled in the pre-operative hold area, give informed consent, and have a dedicated peripheral IV catheter placed. We will recruit patients who are normal weight without diabetes, obese without diabetes, and obese with diabetes. The first specific aim is to characterize the metabolic changes in sugar, fat, and protein balance during surgery in metabolically normal subjects. The second specific aim to examine if there are differences in these changes in subjects who are obese or have diabetes. The final specific aim is to measure the changes in metabolism at high resolution using a method called metabolomics, which is analogous to genome profiling. This method measures hundreds of compounds produced in different amounts as metabolic balance changes.
The major impacts that may be derived from these data range from a more thorough understanding of metabolism under trauma to identification of new markers for risk stratification and intervention to improve clinical outcomes. These data will help build the foundation for new approaches to understanding the physiological and metabolic responses to stress and trauma.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preoxygenation Before General Anesthesia
NCT03802643
Ventilation in Cardiac Surgery
NCT03255356
Evaluation of the Effects of Preoperative Breathing Exercises on Preoxygenation Period
NCT06401096
Benefits of Drinking Clear Fluids Until Called to the Operating Room in Adult Surgical Patients
NCT06253052
Evaluation of Providing Coffee to Patients Postoperatively to Decrease Length of Stay in the PACU
NCT03712891
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The categorical criteria for the groups will be body type: lean (BMI\<25), overweight (BMI \>25, \<30), and obese (BMI \>30 but \<40), and glycemia: normoglycemic (fasting blood glucose; FBG \<100 mg/dL or HbA1c \<5.5%), impaired fasting glucose (FBG \>100 mg/dL and \<126 mg/dL, or HbA1c \>5.5% and \<6.5%), Type 2 Diabetes (FBG \>126 mg/dL or HbA1c \>6.5%).
Subjects will be screened, enrolled, give informed consent, and have a dedicated peripheral IV line placed in pre-operative hold. A baseline blood sample will be collected in pre-operative hold, after transfer to the table in the operating room, and immediately prior to induction of anesthesia. Following induction blood samples will be collected at 15' intervals for the initial 2 hours of each case, then at 30' intervals for the remainder of the case and for 2 hours in the post-anesthesia care unit. Samples will be processed and stored at -80C until analyzed. Intra-operative data from the anesthesia record will be collected and included in the study database.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
surgery
subjects undergoing multilevel lumbar fusion
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Vermont Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
William G Tharp
Assistant Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
M14-291
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.